SST and Alzheimer disease: The tentative conclusion from these incomplete mapping analyses is that there seems to be substantial overlap in the localization of APP/Aβ, the SST or CST cyclic peptides and their receptors, including in AD pathology-relevant regions, such as the hippocampus.